Metraipolis › archive › dc_8b5eb4ae006b

NDR1 enhances USP9X-mediated AR deubiquitination and promotes enzalutamide resistance in castration-resistant prostate cancer — Europe PMC PMID:41079920

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41079920
DOI
10.7150/ijbs.114686
License (as archived)
solo-consultazione
Archived
2026-11-10T03:47:00.886Z
SHA-256 of the archived text
c5231ec7f2812e1c158797d0e2a13093cc2d00c4656c71465446487599087824
Stable URL of this page
https://metraipolis.com/documento/dc_8b5eb4ae006b

How to cite

NDR1 enhances USP9X-mediated AR deubiquitination and promotes enzalutamide resistance in castration-resistant prostate cancer — Europe PMC PMID:41079920 — Europe PMC (en), https://europepmc.org/article/MED/41079920 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8b5eb4ae006b (Metraipolis archive dc_8b5eb4ae006b, sha256 c5231ec7f2812e1c158797d0e2a13093cc2d00c4656c71465446487599087824)
BibTeX
@misc{dc8b5eb4ae006b,
  title = {NDR1 enhances USP9X-mediated AR deubiquitination and promotes enzalutamide resistance in castration-resistant prostate cancer — Europe PMC PMID:41079920},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41079920},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8b5eb4ae006b; sha256 c5231ec7f2812e1c158797d0e2a13093cc2d00c4656c71465446487599087824},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41079920. Agents can read the archived copy with the MCP tool read_document.